Murlentamab-MMAE (ADC)
Murlentamab-MMAE is an ADC consisting of an AMHR2-directed antibody and Monomethyl auristatin E (MMAE) used for the study of colorectal cancer and ovarian cancer.
Product Specifications
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1150289-01 0.02 mg (E-Coli)
Recombinant Clostridium botulinum tRNA-specific 2-thiouridylase mnmA 2 (mnmA2)
Sign In for Pricing
View Details MBS1150289-02 0.02 mg (Yeast)
Recombinant Clostridium botulinum tRNA-specific 2-thiouridylase mnmA 2 (mnmA2)
Sign In for Pricing
View Details MBS1150289-03 0.1 mg (E-Coli)
Recombinant Clostridium botulinum tRNA-specific 2-thiouridylase mnmA 2 (mnmA2)
Sign In for Pricing
View Details MBS1150289-04 0.1 mg (Yeast)
Recombinant Clostridium botulinum tRNA-specific 2-thiouridylase mnmA 2 (mnmA2)
Sign In for Pricing
View Details